K + Mg
Potassium: Physiology and Role
most abundant cation in the body (~3,000 mEq) and is mainly intracellular (98%), with serum levels normally 3.5–5 mEq/L.
Roles: protein/glycogen synthesis, cellular metabolism, regulation of cell membrane electrical action potentials, cardiovascular and neuromuscular function.
Na/K ATPase pump - sustains Potassium gradient across cell membranes
Hypokalemia serum K <3.5 mEq/L.
Clinical Manifestation
Heart: ECG changes, dysrhythmias, conduction defects,
Muscles: weakness, myalgias, cramps, paresthesias, tetany, and paralysis.
Etiologies
Excessive renal loss (90% via kidneys) and GI loss (diarrhea, vomiting, laxatives). Medication-related: Diuretics, mineralocorticoids, cation exchange resins
Intracellular shift from insulin (↑Na/K ATPase activity) or catecholamines stimulating B2 receptors activating the pump or glycogenolysis increasing insulin secretion
Hypomagnesemia impairs Na/K ATPase, worsening renal K loss
correct Mg before K.
range mEq/L | how KCl replace | |
Mild | 3 - 3.5 | PO (tab, cap, liquid) |
Moderate | 2.5 - 3 | IV or PO |
Severe | < 2.5 | IV aaaaaaaaaaaaaaaaaaaaaaaaaaa if risk of serious symptoms or arrhythmias do IV or PO |
Treatment
Replacement Rule: every 100 mEq to raise serum K+ by 1 mEq
IV Supplementation (KAc, KP, KCl)
prepare in saline since dextrose may stimulate insulin
max infusion rate = 10 mEq/h never IV push
ADR - arrhythmia, phlebitis, infusion site pain
Pt Counseling points
GI intolerance (N/V, abdominal pain) take with food and divide dose
Full glass of water or juice to dilute do not crush or chew
can open capsule and sprinkle contents on soft cool food
Hyperkalemia serum K > 5 mEq/L
Clinical Manifestations
Heart: ECG changes, dysrhythmias, conduction defects
Muscle: weakness, twitching, cramps, paralysis
Kidney: metabolic acidosis
Etiologies
Excess intake (rare) - K supplementation overcorrection, dietary noncompliance, salt substitutes
Reduced excretion - Renal failure, hypoaldosteronism (RAAS), medications
ACEi/ARBs, K-sparing diuretics, trimethoprim
Extracellular shift - cell lysis or tumor lysis syndrome, metabolic acidosis, hyperosmolality, insulin deficiency, meds
Digoxin, succinylcholine, non-selective Beta blockers,
Hemolysis - traumatic blood draw causes release of intracellular K causing pseudo-hyperkalemia.
check for apparent cause and wide variability in repeated labs
Treatment
Protect the heart - IV calcium avoiding Na lines for precipitate risk (if ECG changes, not monotherapy)
gluconate 10% (1-3g) or chloride 10% 0.5-1g) both onset of 1-3 mins and lasts 30-60 min
gluconate less irritating to conscious Pt but usually underdosed
chloride higher risk of extravasation and tissue necrosis
Shift K intracellularly - all have onset of 30 min
regular or rapid Insulin ± dextrose 5-10 units ± 25-50 g dextrose IV (BG <250 mg/dL) lasts 2-6 hr
albuterol 10-20 mg nebulizer lasts 1-2 hr
sodium bicarbonate (for acidosis) 50-100 mEq IV lasts 2-6hr
Eliminate K - furosemide or potassium binders
Furosemide (lasix) 20 - 40 mg IV onset 30 min (renal dep) lasts 4-6 hr
Potassium Binders aka cation exchangers
veltassa/patiromer binds to K in GI lumen to exchange for Ca2+
onset 4-7 hour lasts vary
ADR - constipation ,nausea, hypomagnesemia, DDI with PO meds should have 3+ hr gap
Lokelma binds K+ in Gi lumen to exchange for Na and H
onset 1 hour lasts vary
ADR: edema, DDI with PO meds leave 2+ hour gap
Hemodialysis - most effective, invasive, time consuming for emergency or last line
4 hr dose immediate onset with lasts variable
Monitor electrolytes, volume status, renal function, blood glucose
Magnesium
second most abundant intracellular cation; mostly found in bone (67% and muscle (20%)
Serum normal: 0.7–1.25 mmol/L or 1.6-2.5 mg/dL. in body 25 g
Roles: Cofactor for numerous enzymatic and biochem reactions (ATP-dependent), cardiovascular and neuromuscular function.
Hypomagnesemia Serum Mg < 0.7 mmol/L or < 1.6 mg/dL
Clinical Manifestations -
Heart: ECG changes and arrhythmia
Brain: confusion/delirium, seizures, coma, vertical nystagmus (eye twitches)
Muscle: weakness, lethargy, tremor, paresthesia (tingling/numbness), tetany (spasms)
GI: N/V
Etiologies
Inadequate intake/absorption daily ~ 400g
long nasogastric suction, malabsorption, short-bowel syndrome (resection/bypass)
Excess loss: ~95% of renal filtered reabsorbed or GI loss (N/V/D) or defect in renal reabsorption
medication: laxative abuse, diuretics, PPI, aminoglycosides, amphotericin B, cyclosporine, tacrolimus
Chronic Alcoholism - less intake combined with renal and GI loss
Treatment
Route | Indication | Replacement |
PO | >0.5 mmoL asymptomatic | Mg Oxide 400-800 mg BID |
IV | < 0.5 mmoL symptomatic or PO intolerant | Mg sulfate 1 -8 g over 24 hours |
Other Po salts available
gluconate tablet 500 mg
hydroxide tablet or solution 400 mg or 400 mg/5 mL
citrate solution 290 mg/5 mL
lactate tablet (Tab SR) 84 mg reduce diarrhea
chloride (slow mag) 64 mg reduce diarrhea
stagger Mg to avoid DDI to decrease absorption of fluoroquinolones, TCA, mycophenolate, bisphosphatase
IV max 2g/hr with 50% excreted in urine
emergency 2g in 10 mL NS IV push over 1 min
will cause flushing sweating and hypotension
can do IM if IV needed and impossible, but painful
Hypermagnesemia serum Mg > 1.1 mmol/L or > 2.5 mg/dL
Etiologies - Uncommon, but can occur from renal impairment, overcorrection, or excess Mg-containing antacids/laxatives intake
Treatment
Antagonize effects - IV calcium gluconate for cardiac/neuromuscular toxicity
Reduce intake - Discontinue exogenous Mg
Promote elimination - IV fluids, loop diuretics, and hemodialysis with some K if severe.